Upcoming Medical Conferences in Brussels

The ECCO 2019 European Cancer Summit on 12-14 September 2019 in Brussels, Belgium will bring together worldwide leaders from cancer care, research, patient advocacy and public-private sectors in a unique multi-stakeholder forum. The theme of the second edition of the ECCO Summit is: “European Cancer Care: Across Borders”. ​Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders. The ECCO 2019 European Cancer Summit will: • Debate leading-edge ideas in achieving improvement in cancer care • Determine consensus resolutions for improving health care systems • Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice. Who should attend? Current and future leadership and officers from staff and professional levels of: • Representatives of ECCO Member Societies  • Patient organisations including patient advocates • Healthcare providers including hospitals, cancer centres and oncology departments • Healthcare insurance providers and other payer organisations • Education providers • Commercial providers to the healthcare sector • EU and national/regional government officials • Public affairs professionals • Elected policy makers in the healthcare sector • Academic researchers • Regulatory professionals Why should you attend? • The Summit unites the multidisciplinary community • Share knowledge and drive the debate on achieving improvement in cancer care • Demand the changes required to improve patient outcomes • Engage in resolution-forming to shape the EU cancer policy agenda • Translating ideas into policies that will impact daily clinical practice • Network with leaders from cancer health care, patient advocacy and stakeholder communities • Represent your organisation’s voice to the change-making community of European cancer care Additional details will be posted as soon as they are available.

We are delighted to announce you about the International European Conference On Dental and Oral Health Research which is going to be held from 16 -17 September 2019 in Brussels, Belgium. The main aim of Dental Meet 2019 Congress is to bring together researchers, academic scientists, research scholars, professionals, leaders, entrepreneurs, innovators, investors, to trade and share their encounters and research results on all perspectives of Dental & Oral Health Research. Dental Meet 2019 International Conference provides a platform where people can discuss the latest developments, innovative ideas, authoritative views, practical problems and difficulties experienced and solution adopted in the fields of Dental & Its related research. This Conference has been approved for a maximum of 14 CME Credits. Why to Attend? Dental Meet 2019 focuses around Dentist, Dental Surgery, Cosmetic Dentistry, Dental Implant, Oral Diseases, Periodontistry, Orthodontistry, Pediatric Dentistry, Cosmetic Dentistry, Dental Marketing, Dental Business Networking, Dental Insurance, Dental Photography and many more other aspects related to the field of Dental & Oral Health Research. Scientific Sessions: • Dental Implants, Prosthodontics & Periodontology • Oral Pathology, Radiology, Microbiology & Medicine • Preventive Dentistry & Oral Cancer • Dental Care, Tooth Anatomy, Tooth Decay & Dental Erosion • Dental Sleep Medicine and Anticoagulant & Antiplatelet Medications • Dental Surgery • Dental Pharmacology, Oral Medicine & Osteoporosis Medications • Nano Dentistry (Dental Biomaterials & Electronic Dental Instruments) • Endodontic and Restorative Dentistry • Dental Technology & Tools • Digital Dentistry and Imaging • Forensic Dentistry & Odontology • Cosmetic Dentistry • Pediatric Dentistry • Advance Dental Technologies • General & Public Dentistry Kindly submit you’re abstract if you want to attend as a Speaker. It would be great if you are willing to attend the Congress kindly contact us at the earliest. For further queries kindly revert to us, we will be very happy to assist you all the time. Additional details will be posted as soon as they are available.

We are delighted to announce you about the Advanced Therapeutical Conference on Nursing & Midwifery which is going to be held from 16 -17 September 2019 in Brussels, Belgium. The main aim of Nursing Meet 2019 is to bring together Nurses, Registered Nurses Nurse Practitioners, Scientists, Doctors, Professors, research scholars, professionals, leaders, entrepreneurs, innovators, investors, Healthcare Organizers to trade and share their encounters and research results on all perspectives of Nursing and Midwifery. Nursing Meet 2019 provides qualitative, quantitative, and mixed-method research presentations on a variety of topics related to nursing and Midwifery. It connects you with connects you with colleagues as they share knowledge on nursing education, cardiac nursing, oncology nursing, clinical nursing, public health nursing, pediatric nursing, holistic nursing, psychiatric nursing, emergency nursing, etc. This Conference has been approved for a maximum of 15 CME Credits. Who Attends: • Nurses • Registered Nurses • Nurse Practitioners • Scientists • Doctors • Professors • Medical colleges • Nursing Lecturers • Healthcare Industries • Pharmaceutical industries • Directors of Association and Societies • Training Institutes • Healthcare faculty • Researchers • Education Providers • Healthcare Organizations Scientific Sessions to be Covered: • Nursing and Healthcare • Midwifery and women health Nursing • Pediatric Nursing • Psychiatric and Mental Health Nursing  • Critical Care and Emergency Nursing • Cardiovascular Nursing • Surgical Nursing • Clinical Nursing • Holistic Nursing • Occupational Health Nursing • Community Nursing an Family Health Nursing • Advances in Nursing Additional details will be posted as soon as they are available.

ESID 2019: Focused Meeting of the European Society for Immunodeficiencies is organized by European Society for Immunodeficiencies (ESID), Kenes Group and will be held from Sep 18 - 21, 2019 at Square Brussels Convention Centre, Brussels, Belgium. This will be a unique meeting, focusing on the fascinating and important intertwinement between primary immunodeficiencies, infections and malignancy. The very best, internationally distinguished speakers have been selected to cover this field. Topics include: • PIDs with a well-known increased risk of malignancy, such as DNA repair disorders, CVID, T cell deficiencies • The impact of viral infections on the development of malignancies • The immunology of the tumor microenvironment • And much, much more. Issues regarding pathogenesis, diagnosis, treatment and screening will be approached from different viewpoints. ESID 2019 will also include classics such as the Educational Day, Meet the Experts and the latest advances in our field. We invite you to join us at ESID 2019 and be part of the PID community. You will have the opportunity to meet colleagues and friends, learn and share experiences, and enjoy Belgian hospitality. You can also take an active role in the Meeting and submit your abstract until April 16, 2019 Price: ESID Member - Junior Early Bird (unconfirmed): EUR 250.0 Speakers: Isabelle Meyts – ESID President, Jutte van der Werff ten Bosch – ESID 2019 Meeting Chair, Kaan Boztug, Jean-Laurent Casanova, Yanick Crow, Charlotte Cunningham-Rundles, Amos Etzioni, Alain Fischer, Eleonora Gambineri, Steve Holland, Christoph Klein, Taco Kuijpers, Mike Lenardo, Gigi Notarangelo, Mikko Seppanen, Helen Su, Mirjam van der Burg Time: 8:30 am - 1:30 pm Additional details will be posted as soon as they are available.

Upper and Lower GI Tumours 2019 is organized by European Society of Gastrointestinal and Abdominal Radiology (ESGAR) and will be held from Sep 19 - 20, 2019 at Hotel NH Brussels Bloom, Brussels, Belgium. CME Accreditation “The ESGAR Case-based Workshop in Upper and Lower GI Tumours has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with 12 European CME credits (ECMECs). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” Additional details will be posted as soon as they are available.

2019 International Society for Pharmaceutical Engineering (ISPE) Europe Biotechnology Conference is organized by International Society for Pharmaceutical Engineering (ISPE) and will be held from Sep 25 - 26, 2019 at Crowne Plaza Brussels Airport, Brussels, Belgium. Why Attend? Hear what the new megatrends are and how it will influence your operations and shape the future Learn about how to ensure "capable capacities" at CMOs, CROs, and Analytical Laboratories Discover professional ideas on how to develop the "Biotech Workforce of the Future" Learn what industry leaders’ thoughts are for tomorrow Engage with Regulators addressing the regulatory framework for biologics Explore new ways to address patient needs with new product types such as Biosimilars, Biobetters, ADCs, and ATMPs Learn from the challenges in manufacturing personalised medicines Network with colleagues and speakers to learn about best practice ideas and influencer Who Should Attend? Professionals at all levels of the industry from young professionals to the most senior executives, Communities of Practice, special interest groups, pharmaceutical industry equipment and services suppliers, and regulatory professionals.  • Young Professionals  • Senior Executives  • Communities of Practice  • Special Interest Groups  • Equipment and Services Suppliers  • Regulatory Professionals  Description: Biopharmaceuticals has become a main pillar in the pharmaceutical industry, with significant transformation in the development, strategy, technology and operations. This transformation is a continuous process, which is impacted by other developments in digitalisation amongst other factors. Entirely new concepts, such as gene - and cell therapy, are being brought to market, which offer even more possibilities to regenerative medicine or disease remission. However, there are still operational and technological challenges. Reproducing large molecules reliably at an industrial scale requires manufacturing capabilities of a previously unknown complexity and sophistication. The starting material that produce recombinant therapeutics are genetically modified living cells that must be frozen for storage, thawed without damage, and made to grow in a reaction vessel. The molecules must then be separated from the cells that cultivated them and the media in which they were produced, all without destroying their complex, fragile structures. This process requires new technologies and capabilities and will be explored at our conference. Similarly, in GMP and Quality there are challenges, for instance working with a non-sterile starting material in a sterile and aseptic manufacturing process, where it is needed to prove that the micro-organisms are from starting material only and not from processing. Challenges that need new and innovative approaches. The 2019 ISPE Europe Biotechnology Conference will address these topics with industry case studies and plant tours. Most important, the conference will allow for collaborative dialogue with presenters, regulators, industry, peer groups and top managers in an interactive forum. Additional details will be posted as soon as they are available.

Positioning and Immobilisation for Radiotherapy is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Sep 26 - Oct 20, 2019 at ESTRO Office, Brussels, Belgium. Target Audience: The target audience for this course are RTTs who need to develop or improve their knowledge and practical skills in patient positioning and immobilisation for modern radiotherapy techniques. This course is of particular interest to RTT’s who have not completed a dedicated RTT programme and who may lack knowledge in the positioning and immobilisation process. This course provides the theory and practical skills to effectively position and immobilise patients for treatment. Course Design: •  The course will take place over a 4 week period and will be delivered using a blended learning approach, i.e. a combination of recorded online seminars, live teleconferencing and face-to-face teaching: •  The theoretical components will be delivered using Moodle, the ESTRO Virtual Learning Environment (VLE), where recorded seminars will be available for participants to join at a time that suits them •  Additionally, live teleconference tutorials will also take place to provide participants with the opportunity to discuss their learning to date with the teachers. •  The face-to-face component of the course will occur over a two-day period at the ESTO Office and the Department of Radiotherapy, UCL Cliniques Univ. St. Luc in Brussels. This course aims to:  •  The course aims to provide:  •  Knowledge of the impact patient immobilisation and positioning has on the radiotherapy process and treatment outcomes  •  Practical experience of constructing and using immobilisation devices for a range of disease site and treatment techniques  •  A forum for participants to gain and exchange knowledge on patient immobilisation and position Course Content: •  The course will cover the following topics:  •  Basic principles of positioning and immobilisation  •  Impact of positioning and immobilisation on target volume, OAR delineation and treatment planning  •  Immobilising patients for a range of anatomical areas  •  Positioning errors on margins  •  Impact of positioning and immobilisation on:  -   treatment verification  -   clinical outcome  •  Risk and positioning on immobilisation  •  Case discussions Objectives: By the end of this course participants should be able to:  •  Discuss the need for accurate and precise patient immobilisation and positioning in radiotherapy  •  Evaluate the impact of positioning and immobilisation on margins required for adequate dose delivery  •  Construct and optimally use immobilisation devices for a range of anatomical sites  •  Solve difficult cases where conventional immobilisation devices may not be appropriate.   •  Compare and evaluate the efficacy of immobilisation devices/positions   •  Evaluate positioning and immobilisation procedures in the context of radiotherapy risk management. Additional details will be posted as soon as they are available.

The 4th EAAR Annual Congress on New Medical Device Regulations (RMD2019) is organized by Bioevents and will be held from Oct 28 - 29, 2019 at Steigenberger Wiltcher's, Brussels, Belgium. Description: In conjunction with EAAR (European Association of Authorized Representatives), our excellent panel of experienced professionals in this field will once again ensure a congress of noteworthy quality. Topics to be covered, among others will be: • Implementation of the New Regulations • The Road to 2020: Overview of Regulatory Developments • Major Regulatory Compliance Challenges for the Industry • Challenges for National Competent Authorities • New Legal Challenges to the Medical Device Industry • Scope, Borderlines and Classification • General Safety and Performance Requirements • Practical Aspects of Clinical Evaluation: What needs to be updated now and  how to plan for  Future Compliance under the MDR • Impact of the MD/IVD-Regulations on Quality Management Systems • View of a Notified Body on the MDR Implementation Steps • Post-Market Surveillance • Do you need to plan for PMCF and What are the Possibilities for Gathering PMCF Data? • The Impact of Increased Transparency and Traceability Resulting from Eudamed and the  Introduction of UDI • Vigilance • What can we Expect from the MDR Authorized Representative? • Special IVD Issues • Software • Conflicts Between Economic Operators  Additional details will be posted as soon as they are available.

Multidisciplinary Management of Non-melanoma Skin Cancer (NMSC) Conference is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Nov 07 - 09, 2019 at ESTRO Office, Brussels, Belgium. Target Group: This advanced multidisciplinary course is aimed at radiation oncologist and clinical oncologists, dermatologists, surgeons, allied health care professionals and other specialists and trainees who have a special interest in non-melanoma skin cancer (NMSC) and would like to update their knowledge in the multidisciplinary management of patients with NMSC. The course may also be of interest to medical physicists and radiographers who would like an overview of the current practicein NMSC. Description: The course will be interactive and including a variety of teaching methods. There will be also special sessions covering extended content dedicated to Mohs’ and plastic surgery, and skin radiotherapy, brachytherapy and radiobiology for those participants who wish for advanced knowledge in the relevant fields. Course Aim: • Provide a comprehensive overview of current management options in NMSC • Highlight the need for improved interdisciplinary collaboration • Concept and management of high risk, locally advanced and metastatic NMSC • NMSC in special circumstances and rare skin pathologies • Clinical consultation of NMSC patient • Role of multidisciplinary team meetings in the management of NMSC • Overview of current research, clinical trials and technical developments in NMSC. Course Objectives: By the end of this course participants should be able to: • Understand prophylaxis, epidemiology and pathology of NMSC with special focus on basal, squamous and Merkel cell carcinoma. Rare skin cancers will also be included. • Discuss advantages and limitations of imaging modalities used for diagnosis and treatment of NMSC • Understand indications and limitations of surgical and non-surgical treatment modalities in NMSC • Develop a deep understanding of best practices in NMSC and provide patients with the best possible treatment, skin care advice and follow-up care • Understand challenges of palliative and supportive care in NMSC patients • Have a general understanding of principles in geriatric oncology and integrate geriatric oncology assessment into clinical practice involving NMSC patients • Summarise the latest technical developments and gain knowledge of future directions in research and clinical trials in the management of NMSC. Course Content: Epidemiology,prevention, pathology and bio-markers of NMSC • The role of imaging in diagnosis and treatment of NMSC • Surgical and non-surgical treatments of NMSC • Physics and mould room input in dermatological radiotherapy and brachytherapy • Radiobiology of the skin • Follow-up and management of side effects during and after skin cancer treatment • Role of allied health care professionals in NMSC management surgical and non-surgical treatment modalities in NMSC • Have at least basic experience with radiation therapy for NMSC patients. If the participant is not a radiation oncologist or clinical oncologist (including training post) they should be involved in multidisciplinary case discussions or have special interest in NMSC patients • Be prepared to ask questions and contribute to live and interactive discussions. Additional details will be posted as soon as they are available.

Palliative Care and Radiotherapy - A Course on Prognosis, Symptom Control, Re-Irradiation and Oligometastases is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Nov 26 - 28, 2019 at ESTRO Office, Brussels, Belgium. Target Group : This basic course is aimed primarily at trainee radiation and medical oncologists and experienced radiation and medical oncologists who want an update of their clinical knowledge. Clinical physicists, palliative care physicians and specialist nurses are welcome to participate. Description : In this course, a comprehensive overview of the applicability and effectiveness of palliative radiotherapy schedules from an evidence based perspective will be provided in a multidisciplinary framework. Focus will be on both clinical-ethical aspects and more technical-physics related issues. Learning outcomes : By the end of this course participants should  • Have knowledge of the principles of palliation, pain management, and indications for and effectiveness of palliative radiotherapy schedules • Be able to discuss clinical cases on management, expected survival, clinical outcome in terms of quality of life and side effects using evidence based outcome tools. Course Content : • Principles of palliation, oligometastasis • Nature of cancer pain, physiology of pain • Principles of pharmacological management • Radiotherapy for pain: bone pain, soft tissue pain • Holistic pain therapy: integration of RT/CT/pharmacology and non-pharmacological approaches • Neurological complications: brain metastases - introduction and pharmacological management • Management of solitary brain metastases Management of multiple brain metastases • Malignant spinal metastasis, pathophysiology, diagnosis and initial management • Management of malignant spinal canal compression • Other neurological complications: spinal nerve root compression and neuropathic pain management • Care of the dying: different models of care • Lung - NSCLC: palliative management • Oligometastases and ablative therapy • Liver: role of radiotherapy in palliation • Palliative brachytherapy • Practical application of research data in palliation. Prerequisites : Before commencing this course you should have a basic understanding of radiotherapy and pharmacology and experience of caring for patients with advanced cancer. Additional details will be posted as soon as they are available.